Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model

Area of Science:

• Genetics
• Hematology
• Oncology

Background:

• Fanconi anemia (FA) is an autosomal recessive disorder characterized by congenital malformations, bone marrow failure, and cancer predisposition.
• FA cells exhibit chromosomal instability and hypersensitivity to DNA cross-linking agents like mitomycin C (MMC) and diepoxybutane (DEB).
• Genetic defects in FA involve at least eight complementation groups, with FA(A) and FA(C) genes identified.

Purpose of the Study:

• To establish and characterize an in vitro model for studying cellular defects in Fanconi anemia.
• To investigate the hypersensitivity of mouse fibroblast cell lines with Fanconi anemia complementation group C (FAC) mutations to DNA cross-linking agents.

Main Methods:

• Development of mouse models for FA(C) by gene targeting.
• Establishment of transformed mouse fibroblast cell lines from these models.
• Cell-killing assays and cytogenetic analyses following treatment with MMC and DEB.

Main Results:

• Mice homozygous for Fac mutations (Fac-/-) displayed reduced fertility and increased chromosomal aberrations upon MMC and DEB exposure.
• Transformed Fac-/- mouse fibroblasts showed significant hypersensitivity to MMC and DEB compared to wild-type (Fac+/+) and heterozygous (Fac+/-) cells.
• These cellular phenotypes in mouse fibroblasts mirror findings in human FA cell lines.

Conclusions:

• Isogenic transformed mouse fibroblasts from Fac-/- mice provide a valuable in vitro model for Fanconi anemia research.
• This model facilitates further investigation into the cellular mechanisms underlying hypersensitivity to DNA cross-linking agents in FA.
• The study validates the utility of these mouse models for understanding FA pathogenesis and potential therapeutic strategies.